Cargando…
Preamble to the 2015 SITC immunotherapy biomarkers taskforce
The Society for Immunotherapy of Cancer (SITC) has regularly hosted workshops and working groups focused on immunologic monitoring and immune biomarkers. Due to advances in cancer immunotherapy, including positive results from clinical trials testing new agents and combinations, emerging new technol...
Autores principales: | Butterfield, Lisa H, Disis, Mary L, Fox, Bernard A, Khleif, Samir N, Marincola, Francesco M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371796/ https://www.ncbi.nlm.nih.gov/pubmed/25806107 http://dx.doi.org/10.1186/s40425-015-0052-6 |
Ejemplares similares
-
A systematic approach to biomarker discovery; Preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers"
por: Butterfield, Lisa H, et al.
Publicado: (2008) -
Immuno-Oncology biomarkers 2010 and beyond: Perspectives from the iSBTc/SITC biomarker task force
por: Butterfield, Lisa H, et al.
Publicado: (2010) -
SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the Art
por: Butterfield, Lisa H., et al.
Publicado: (2018) -
Society for immunotherapy of cancer (SITC) statement on the proposed changes to the common rule
por: Kaufman, Howard L., et al.
Publicado: (2016) -
SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document: Online resources and useful tools - a compass in the land of biomarker discovery
por: Bedognetti, Davide, et al.
Publicado: (2011)